Stryker Corporation SYK
Mixed Medical Devices & Diagnostics sector · Stryker — orthopedics, surgical robotics (Mako) and medtech with a deep installed base.
Stryker Corporation (SYK) is an established Medical Devices & Diagnostics company, graded Mixed on FrontierLab's evidence-based quality rubric (data as of 2026-08-21). Revenue grew 8.5% year-over-year at a 65.2% gross margin. Gross-profits-to-assets is 0.35; Rule of 40 is 30.5. Net share issuance -0.1% YoY (flat share count). No risk flags are currently noted. Analyst mix: 28 buy / 6 hold / 0 sell.
These sentences are generated from the day's data by deterministic templates.
Key quality signals
| Revenue growth (YoY) | 8.5% |
|---|---|
| Gross margin | 65.2% |
| Gross profits / assets | 0.35 |
| Rule of 40 | 30.5 |
| Net margin | 22% |
| Cash runway (months) | — |
| PEG | 1.2 |
| Price / sales | 4.9 |
Quality checklist
Each line is one quality test behind the grade — ✓ passed · ~ borderline · ✗ failed. Hover a metric in the tables below for what it means.
- ✗ Revenue growth — 8.5% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.35 (pass ≥ 0.33)
- · Rule of 40 — 30.5 (context — graded for software only)
- ✓ Gross margin — 65.2% (pass ≥ 60% · Medical Devices & Diagnostics)
- ✓ Cash generation
- ✓ Share dilution — -0.1%
- ✓ Competitive moat — Wide
- ✓ Market size (TAM) — Large
Grade history
Graded Mixed since 2026-06-17 — no grade changes recorded yet.
How have Mixed-graded names performed?
The forward returns of all Mixed-graded names since each grade was recorded — the bucket this name currently sits in, not a forecast of this individual stock.
| Window | Forward record vs the S&P | Median |
|---|---|---|
| ~1 month | 53% of Mixed-graded names beat the S&P over 21 sessions (95% CI 31–74%, N=17). | Median excess vs the S&P was 0%. |
| ~3 months | building — 13 more sessions needed | |
| ~6 months | building — 76 more sessions needed | |
Scope: these are forward returns vs the S&P among names still covered at each horizon's end, within the curated universe — not a survivorship-clean whole-market backtest. Names later dropped from coverage are counted as attrition (not hidden), and single-session moves beyond ±300% are treated as split/data artifacts and excluded. How this is measured → · Full track record →
How it compares
Coarse same-sector, same-stage context — not a percentile or rank. GP/A is graded on its absolute level, not position.
Fundamentals
| Market cap | $125.63B |
|---|---|
| Stage | Established |
| Share issuance (YoY) | -0.1% · flat share count |
| Moat | Wide |
| TAM | LARGE |
| P/E (trailing) | 34 |
| EPS (trailing) | $9.65 |
| Burn multiple | — |
| Gross-margin trend (pts) | 3 |
| Cash / assets | 0.07 |
| Accruals (%) | -3.8% |
| Net debt / EBITDA | 1.8 |
| Statements as of | Q2 FY2026 · filed 2026-07-31 |
Momentum context — describes the past, not a signal
Low reached May 11, 2026 · high reached Sep 4, 2025 — by daily close.
| Price | $327.70 (as of 2026-08-20) |
|---|---|
| Last session move | — |
| % off 52-wk high | -17.4% |
| RSI (14) | 46 |
| Relative volume | 0.9× |
Insider activity (90 days)
| Cluster buyers | 0 |
|---|---|
| Sellers | 2 |
Insider selling is routine diversification, not a bearish signal.
Analyst mix
| Strong buy | 13 |
|---|---|
| Buy | 15 |
| Hold | 6 |
| Sell | 0 |
| Strong sell | 0 |
▲ Analyst view improving — net +1 buy rating, coverage 35→34 analysts over ~4 weeks (per aggregated analyst ratings)
Ratings are context, not a price target. "Momentum" = how the mix changed over recent weeks, not a forecast.
From the headlines
Q2 results disappointing but sell-off may present entry opportunity.
AI take — daily, AI-generated
AI leans mixed
Slowest grower here with mixed execution, but the sell-off may have created a reasonable entry point for a patient investor at a 1.2 PEG.
Generated by an AI model from the day's news — an opinion for context only. Not financial advice, not a recommendation, and not a price target.
Similar Medical Devices & Diagnostics names
← All Medical Devices & Diagnostics names · Open SYK in the interactive screener →
Data as of 2026-08-21 08:12 (end-of-day). How grades are computed →